IDT Opens Molecular Biology R&D Facility in Redwood City
Dr Caifu Chen to lead new product development at California site
Research and development for Integrated DNA Technologies' (IDT) validated molecular biology products will now be performed in a newly built facility in Redwood City, California. The 8,000 square foot building houses state-of-the-art labs that will allow IDT scientists to maximize the company’s world-class custom oligonucleotide manufacturing capability.
“For years we’ve focused on enabling research,” said Stephen Gunstream, Chief Commercial Officer. “Redwood City takes that mission to the next level. Now, in addition to our traditional offerings, we will be able to develop complete workflow solutions for cutting edge applications. This provides more value to our customers.”
To lead Redwood City’s Product Development Team, IDT announced that Dr Caifu Chen has joined the company as Senior Vice President for Research and Development. Dr Chen has 25 years of genomics research experience in the academic and biotech sectors, particularly in developing qPCR- and NGS-based assay products for research and diagnostics applications.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Can proteins bind based only on their shapes? - A team using the nation’s fastest supercomputer to look at protein binding finds that some binding processes are simpler than expected

Acrongenomics, Inc. - Genf, Switzerland

Intestinal bacteria could influence the development of multiple sclerosis

New study on the benefits of Covid-19 nasal spray vaccination - Another milestone reached: researchers work together with Swiss biotech start-up to further develop the vaccine
Oil dispersants can suppress natural oil-degrading microorganisms

Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP) - Berlin, Germany
Translational Genomics Research Institute (TGEN) - Phoenix, USA
IDT’s San Diego Manufacturing Facility Receives ISO 14001 Certification

Watching myelin patterns form - First-ever “live” observation of formation and repair of myelin sheaths around nerve fibers

White biotechnology enables carbon recycling - LanzaTech and BASF achieve first milestone in utilizing industrial off-gases for chemical production
Scailyte raises CHF 2.75M in seed funding - Investments from Swisscom Ventures & Zürcher Kantonalbank
